<p>随着欧洲市场在地缘政治紧张局势和波动的能源价格驱动下应对不确定性，泛欧 STOXX 欧洲 600 指数显示出适度的涨幅，反映出投资者的谨慎乐观。在这种环境下，内部持股比例高的成长型公司尤其吸引人，因为它们通常表现出管理层与股东利益之间的强烈一致性，可能在市场波动中提供韧性。</p>
<h3>欧洲内部持股比例高的十大成长型公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>34.7%</td>
</tr>
<tr>
<td>MedinCell (ENXTPA:MEDCL)</td>
<td>11.5%</td>
<td>117.6%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>35%</td>
<td>80.1%</td>
</tr>
<tr>
<td>Induct (OB:INDCT)</td>
<td>10.5%</td>
<td>98.6%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>21.6%</td>
<td>124.9%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.4%</td>
<td>42.7%</td>
</tr>
<tr>
<td>Clavister Holding AB (publ.) (OM:CLAV)</td>
<td>18%</td>
<td>116.2%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>21.9%</td>
<td>88.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.2%</td>
<td>34%</td>
</tr>
<tr>
<td>Bergen Carbon Solutions (OB:BCS)</td>
<td>10.2%</td>
<td>55.5%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们快速成长的欧洲内部持股比例高的 221 只股票的完整列表。</p>
<p>让我们深入探讨一些筛选出的优质选择。</p>
<h2>P/F Bakkafrost (OB:BAKKA)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> P/F Bakkafrost 及其子公司在北美、西欧、东欧、亚洲及其他国际市场从事三文鱼产品的生产和销售；其市值为 268.5 亿挪威克朗。</p>
<p><strong>运营：</strong> 公司的收入细分包括销售及其他收入为 102.8 亿丹麦克朗，法罗群岛养殖为 40.5 亿丹麦克朗，鱼粉、油和饲料为 26 亿丹麦克朗，服务为 9.2052 亿丹麦克朗，苏格兰养殖为 11.2 亿丹麦克朗，法罗群岛淡水养殖为 8.9677 亿丹麦克朗，苏格兰淡水养殖为 1.6946 亿丹麦克朗。</p>
<p><strong>内部持股比例：</strong> 23.7%</p>
<p><strong>收益增长预测：</strong> 每年 36%。</p>
<p>P/F Bakkafrost 是一家内部持股比例高的欧洲成长型公司，预计年收益增长将达到 36%，超过挪威市场。尽管其交易价格大幅低于估计的公允价值，但公司的收入增长预计为每年 12.6%。最近对其章程的修订允许回购最多 10% 的总资本。然而，最近的收益显示年净收入有所下降，尽管季度有所改善。</p>
<ul>
<li>点击这里发现 P/F Bakkafrost 的细微差别，查看我们的详细分析未来增长报告。</li>
<li>我们最近的估值报告指出 P/F Bakkafrost 的股票在市场上可能被低估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/46d88a0e-736c-49a8-b85c-575da11fb6fe/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/46d88a0e-736c-49a8-b85c-575da11fb6fe/chart/earnings-and-revenue-growth"/></p>
<p>OB:BAKKA 收益和收入增长截至 2026 年 4 月</p>
<h2>Sdiptech (OM:SDIP B)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Sdiptech AB（上市公司）在多个国家（包括瑞典、英国和美国）提供基础设施的技术服务，市值为 76.3 亿瑞典克朗。</p>
<p><strong>运营：</strong> 公司的收入细分包括安全与安保（4.3 亿瑞典克朗）、水与生物经济（9.13 亿瑞典克朗）、能源与电气化（10.7 亿瑞典克朗）和供应链与运输（20.8 亿瑞典克朗）。</p>
<p><strong>内部持股比例：</strong> 11.6%</p>
<p><strong>收益增长预测：</strong> 每年 51.6%。</p>
<p>Sdiptech 内部持股比例高，预计年收益将增长 51.59%，并在三年内实现盈利，超过市场平均增长。尽管交易价格低于估计的公允价值 54.2%，分析师预计价格将上涨 35.1%，但公司面临高债务水平。最近的活动包括以 1.84 亿瑞典克朗赎回优先股和以溢价回购价值 2.5 亿瑞典克朗的债券，表明在其增长轨迹中进行战略财务重组的努力。</p>
<ul>
<li>点击这里深入了解 Sdiptech 的完整分析未来增长报告。</li>
<li>我们的估值报告揭示了 Sdiptech 的股票可能在折扣交易。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/087f171a-1bc7-42f1-8527-d29f5f936469/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/087f171a-1bc7-42f1-8527-d29f5f936469/chart/earnings-and-revenue-growth"/></p>
<p>OM:SDIP B 收益和收入增长截至 2026 年 4 月</p>
<h2>Redcare Pharmacy (XTRA:RDC)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Redcare Pharmacy NV 在多个欧洲国家（包括荷兰、德国、意大利、比利时、瑞士、奥地利和法国）经营在线药房业务，市值为 7.4895 亿欧元。</p>
<p><strong>运营：</strong> 公司的收入分为来自 DACH 地区的 24 亿欧元和国际市场的 5.4 亿欧元。</p>
<p><strong>内部持股比例：</strong> 13.7%</p>
<p><strong>收益增长预测：</strong> 每年 53.5%。</p>
<p>Redcare Pharmacy 内部持股比例高，预计在三年内实现盈利并超过市场平均增长。尽管交易价格低于其估计公允价值 79.8%，但面临高股价波动和 2025 年 3700 万欧元的净亏损等挑战。预计 2026 年收入将增长 13-15%，受益于数字医疗创新，如德国远程医疗基础设施现代化中的电子处方 PoPP 模块。</p>
<ul>
<li>点击这里深入了解 Redcare Pharmacy 的具体情况，查看我们的详细增长预测报告。</li>
<li>根据我们的估值报告，Redcare Pharmacy 的股价可能处于较低水平。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bd9541e9-75b0-454c-8046-a7084a97c9e9/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bd9541e9-75b0-454c-8046-a7084a97c9e9/chart/ownership-breakdown"/></p>
<p>XTRA:RDC 股权结构截至 2026 年 4 月</p>
<h2>利用机会</h2>
<ul>
<li>点击此链接深入了解我们快速成长的欧洲内部持股比例高的 221 家公司。</li>
<li>准备好不同的方式了吗？寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
<p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和盈利增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
<h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
<p>我们为股票投资者创建了 <strong>终极投资组合伴侣</strong>，<strong>而且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
<p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
<p>• 跟踪您股票的公允价值</p>
<p>免费试用演示投资组合</p>

BAKK

<p>本文讨论了三家欧洲成长型公司，它们的内部持股比例较高：P/F Bakkafrost、Sdiptech 和 Redcare Pharmacy。P/F Bakkafrost 的内部持股比例为 23.7%，预计年收益增长将达到 36%，尽管最近净收入有所下降。Sdiptech 的内部持股比例为 11.6%，预计年收益增长为 51.6%，但面临高债务水平。Redcare Pharmacy 的内部持股比例为 13.7%，预计年收益增长为 53.5%，同时其交易价格显著低于估算的公允价值。文章强调了这些公司在市场波动中潜在的韧性</p>

<p>As the European markets navigate through uncertainty driven by geopolitical tensions and fluctuating energy prices, the pan-European STOXX Europe 600 Index has shown modest gains, reflecting cautious optimism among investors. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong alignment between management and shareholder interests, potentially offering resilience amid market volatility.</p>
<div class="lb-trans"><p>随着欧洲市场在地缘政治紧张局势和波动的能源价格驱动下应对不确定性，泛欧 STOXX 欧洲 600 指数显示出适度的涨幅，反映出投资者的谨慎乐观。在这种环境下，内部持股比例高的成长型公司尤其吸引人，因为它们通常表现出管理层与股东利益之间的强烈一致性，可能在市场波动中提供韧性。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Europe</h3>
<div class="lb-trans"><h3>欧洲内部持股比例高的十大成长型公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>34.7%</td>
</tr>
<tr>
<td>MedinCell (ENXTPA:MEDCL)</td>
<td>11.5%</td>
<td>117.6%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>35%</td>
<td>80.1%</td>
</tr>
<tr>
<td>Induct (OB:INDCT)</td>
<td>10.5%</td>
<td>98.6%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>21.6%</td>
<td>124.9%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.4%</td>
<td>42.7%</td>
</tr>
<tr>
<td>Clavister Holding AB (publ.) (OM:CLAV)</td>
<td>18%</td>
<td>116.2%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>21.9%</td>
<td>88.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.2%</td>
<td>34%</td>
</tr>
<tr>
<td>Bergen Carbon Solutions (OB:BCS)</td>
<td>10.2%</td>
<td>55.5%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股比例</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>MilDef Group (OM:MILDEF)</td>
<td>13.7%</td>
<td>34.7%</td>
</tr>
<tr>
<td>MedinCell (ENXTPA:MEDCL)</td>
<td>11.5%</td>
<td>117.6%</td>
</tr>
<tr>
<td>KebNi (OM:KEBNI B)</td>
<td>35%</td>
<td>80.1%</td>
</tr>
<tr>
<td>Induct (OB:INDCT)</td>
<td>10.5%</td>
<td>98.6%</td>
</tr>
<tr>
<td>Elliptic Laboratories (OB:ELABS)</td>
<td>21.6%</td>
<td>124.9%</td>
</tr>
<tr>
<td>CTT Systems (OM:CTT)</td>
<td>17.4%</td>
<td>42.7%</td>
</tr>
<tr>
<td>Clavister Holding AB (publ.) (OM:CLAV)</td>
<td>18%</td>
<td>116.2%</td>
</tr>
<tr>
<td>Circus (XTRA:CA1)</td>
<td>21.9%</td>
<td>88.1%</td>
</tr>
<tr>
<td>Bonesupport Holding (OM:BONEX)</td>
<td>10.2%</td>
<td>34%</td>
</tr>
<tr>
<td>Bergen Carbon Solutions (OB:BCS)</td>
<td>10.2%</td>
<td>55.5%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 221 stocks from our Fast Growing European Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们快速成长的欧洲内部持股比例高的 221 只股票的完整列表。</p>
</div><p>Let's dive into some prime choices out of the screener.</p>
<div class="lb-trans"><p>让我们深入探讨一些筛选出的优质选择。</p>
</div><h2>P/F Bakkafrost (OB:BAKKA)</h2>
<div class="lb-trans"><h2>P/F Bakkafrost (OB:BAKKA)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> P/F Bakkafrost, along with its subsidiaries, is involved in the production and sale of salmon products across North America, Western Europe, Eastern Europe, Asia, and other international markets; it has a market cap of NOK26.85 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> P/F Bakkafrost 及其子公司在北美、西欧、东欧、亚洲及其他国际市场从事三文鱼产品的生产和销售；其市值为 268.5 亿挪威克朗。</p>
</div><p><strong>Operations:</strong> The company's revenue segments include Sales and Other at DKK10.28 billion, Farming Faroe Islands at DKK4.05 billion, Fishmeal, Oil and Feed at DKK2.60 billion, Services at DKK920.52 million, Farming Scotland at DKK1.12 billion, Freshwater Faroe Islands at DKK896.77 million, and Freshwater Scotland at DKK169.46 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入细分包括销售及其他收入为 102.8 亿丹麦克朗，法罗群岛养殖为 40.5 亿丹麦克朗，鱼粉、油和饲料为 26 亿丹麦克朗，服务为 9.2052 亿丹麦克朗，苏格兰养殖为 11.2 亿丹麦克朗，法罗群岛淡水养殖为 8.9677 亿丹麦克朗，苏格兰淡水养殖为 1.6946 亿丹麦克朗。</p>
</div><p><strong>Insider Ownership:</strong> 23.7%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 23.7%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 36% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 36%。</p>
</div><p>P/F Bakkafrost, a European growth company with significant insider ownership, is forecast to achieve substantial earnings growth of 36% annually, outpacing the Norwegian market. Despite trading at a considerable discount to its estimated fair value, the company's revenue growth is projected at 12.6% per year. Recent amendments in its Articles of Association allow share buybacks up to 10% of total capital. However, recent earnings showed a decline in annual net income despite quarterly improvements.</p>
<div class="lb-trans"><p>P/F Bakkafrost 是一家内部持股比例高的欧洲成长型公司，预计年收益增长将达到 36%，超过挪威市场。尽管其交易价格大幅低于估计的公允价值，但公司的收入增长预计为每年 12.6%。最近对其章程的修订允许回购最多 10% 的总资本。然而，最近的收益显示年净收入有所下降，尽管季度有所改善。</p>
</div><ul>
<li>Click here to discover the nuances of P/F Bakkafrost with our detailed analytical future growth report.</li>
<li>Insights from our recent valuation report point to the potential undervaluation of P/F Bakkafrost shares in the market.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里发现 P/F Bakkafrost 的细微差别，查看我们的详细分析未来增长报告。</li>
<li>我们最近的估值报告指出 P/F Bakkafrost 的股票在市场上可能被低估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/46d88a0e-736c-49a8-b85c-575da11fb6fe/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/46d88a0e-736c-49a8-b85c-575da11fb6fe/chart/earnings-and-revenue-growth"/></p>
<p>OB:BAKKA Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>OB:BAKKA 收益和收入增长截至 2026 年 4 月</p>
</div><h2>Sdiptech (OM:SDIP B)</h2>
<div class="lb-trans"><h2>Sdiptech (OM:SDIP B)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Sdiptech AB (publ) offers technical services for infrastructures across several countries including Sweden, the United Kingdom, and the United States, with a market cap of SEK7.63 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Sdiptech AB（上市公司）在多个国家（包括瑞典、英国和美国）提供基础设施的技术服务，市值为 76.3 亿瑞典克朗。</p>
</div><p><strong>Operations:</strong> The company's revenue segments include Safety &amp; Security (SEK430 million), Water &amp; Bioeconomy (SEK913 million), Energy &amp; Electrification (SEK1.07 billion), and Supply Chain &amp; Transportation (SEK2.08 billion).</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入细分包括安全与安保（4.3 亿瑞典克朗）、水与生物经济（9.13 亿瑞典克朗）、能源与电气化（10.7 亿瑞典克朗）和供应链与运输（20.8 亿瑞典克朗）。</p>
</div><p><strong>Insider Ownership:</strong> 11.6%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 11.6%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 51.6% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 51.6%。</p>
</div><p>Sdiptech, with strong insider ownership, is expected to grow earnings by 51.59% annually and become profitable within three years, surpassing average market growth. Although trading 54.2% below estimated fair value and analysts anticipate a 35.1% price increase, the company faces high debt levels. Recent activities include redeeming preference shares for SEK 184 million and repurchasing bonds worth SEK 250 million at a premium, indicating strategic financial restructuring efforts amidst its growth trajectory.</p>
<div class="lb-trans"><p>Sdiptech 内部持股比例高，预计年收益将增长 51.59%，并在三年内实现盈利，超过市场平均增长。尽管交易价格低于估计的公允价值 54.2%，分析师预计价格将上涨 35.1%，但公司面临高债务水平。最近的活动包括以 1.84 亿瑞典克朗赎回优先股和以溢价回购价值 2.5 亿瑞典克朗的债券，表明在其增长轨迹中进行战略财务重组的努力。</p>
</div><ul>
<li>Delve into the full analysis future growth report here for a deeper understanding of Sdiptech.</li>
<li>Our valuation report unveils the possibility Sdiptech's shares may be trading at a discount.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里深入了解 Sdiptech 的完整分析未来增长报告。</li>
<li>我们的估值报告揭示了 Sdiptech 的股票可能在折扣交易。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/087f171a-1bc7-42f1-8527-d29f5f936469/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/087f171a-1bc7-42f1-8527-d29f5f936469/chart/earnings-and-revenue-growth"/></p>
<p>OM:SDIP B Earnings and Revenue Growth as at Apr 2026</p>
<div class="lb-trans"><p>OM:SDIP B 收益和收入增长截至 2026 年 4 月</p>
</div><h2>Redcare Pharmacy (XTRA:RDC)</h2>
<div class="lb-trans"><h2>Redcare Pharmacy (XTRA:RDC)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Redcare Pharmacy NV operates an online pharmacy business across several European countries including the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €748.95 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Redcare Pharmacy NV 在多个欧洲国家（包括荷兰、德国、意大利、比利时、瑞士、奥地利和法国）经营在线药房业务，市值为 7.4895 亿欧元。</p>
</div><p><strong>Operations:</strong> The company's revenue is segmented into €2.40 billion from the DACH region and €540 million internationally.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入分为来自 DACH 地区的 24 亿欧元和国际市场的 5.4 亿欧元。</p>
</div><p><strong>Insider Ownership:</strong> 13.7%</p>
<div class="lb-trans"><p><strong>内部持股比例：</strong> 13.7%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 53.5% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 53.5%。</p>
</div><p>Redcare Pharmacy, with significant insider ownership, is forecast to achieve profitability within three years and surpass average market growth. Despite trading at 79.8% below its estimated fair value, it faces challenges like high share price volatility and a net loss of €37.7 million in 2025. Revenue is expected to grow between 13-15% in 2026, driven by digital healthcare innovations such as the PoPP module for e-prescriptions in Germany's telematics infrastructure modernization.</p>
<div class="lb-trans"><p>Redcare Pharmacy 内部持股比例高，预计在三年内实现盈利并超过市场平均增长。尽管交易价格低于其估计公允价值 79.8%，但面临高股价波动和 2025 年 3700 万欧元的净亏损等挑战。预计 2026 年收入将增长 13-15%，受益于数字医疗创新，如德国远程医疗基础设施现代化中的电子处方 PoPP 模块。</p>
</div><ul>
<li>Dive into the specifics of Redcare Pharmacy here with our thorough growth forecast report.</li>
<li>According our valuation report, there's an indication that Redcare Pharmacy's share price might be on the cheaper side.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里深入了解 Redcare Pharmacy 的具体情况，查看我们的详细增长预测报告。</li>
<li>根据我们的估值报告，Redcare Pharmacy 的股价可能处于较低水平。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/bd9541e9-75b0-454c-8046-a7084a97c9e9/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/bd9541e9-75b0-454c-8046-a7084a97c9e9/chart/ownership-breakdown"/></p>
<p>XTRA:RDC Ownership Breakdown as at Apr 2026</p>
<div class="lb-trans"><p>XTRA:RDC 股权结构截至 2026 年 4 月</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Click this link to deep-dive into the 221 companies within our Fast Growing European Companies With High Insider Ownership screener.</li>
<li>Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击此链接深入了解我们快速成长的欧洲内部持股比例高的 221 家公司。</li>
<li>准备好不同的方式了吗？寻找现金流潜力良好但交易价格低于其公允价值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇来自 Simply Wall St 的文章具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，采用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中均没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具（如公司和/或信托实体）间接持有的股票。所有预测的收入和盈利增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合伴侣</strong>，<strong>而且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看您的总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警告信号或风险提示</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪您股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

三家欧洲成长型公司拥有高内部持股